Collagen Peptides vs Matrixyl
Collagen peptides are taken orally and studied for skin elasticity and hydration in randomised trials; Matrixyl is applied topically as a short signal peptide.
Collagen Peptides
Enzymatically hydrolysed collagen taken orally, studied in randomised trials for skin, joint and bone outcomes.
BEST STUDIED FOR
Skin peptides
Read the cited profile →
Matrixyl
A lipidated fragment of type I pro-collagen (Lys-Thr-Thr-Lys-Ser) used as a topical "signal peptide" to stimulate matrix production.
BEST STUDIED FOR
Skin peptides
Read the cited profile →
SIDE BY SIDE
| Collagen Peptides | Matrixyl | |
|---|---|---|
| The key difference | Oral hydrolysed collagen | Topical signal peptide |
| Class | Skin peptides | Skin peptides |
| Mechanism | Small collagen-derived di- and tripeptides (e.g. | KTTKS is a pro-collagen subfragment reported to feed back on fibroblasts to increase collagen and other matrix components; the palmitoyl chain improves skin penetration and stability. |
| Status | Food supplement with multiple small randomised trials in skin ageing, activity-related knee pain and postmenopausal bone density. | Cosmetic ingredient with small clinical studies and in-vitro work; delivery systems remain an active topic. |
| Reported safety signals | Trials report it as well tolerated. | Topical studies report good tolerability. |
| A key study | A randomised trial measured wrinkle volume and dermal matrix markers with oral collagen peptides. (Skin Pharmacol Physiol 2014, PMID 24401291) | A clinical study measured changes in photoaged facial skin with topical pal-KTTKS. (Int J Cosmet Sci 2005, PMID 18492182) |
WHEN TO RESEARCH WHICH
Collagen peptides for oral-supplement research; Matrixyl for topical formulations. Both are discussed here strictly as research compounds; nothing on this page is medical advice or a dosing guide.
REFERENCES (PUBMED)
- [Collagen Peptides] Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis — Skin Pharmacol Physiol 2014. PMID 24401291
- [Collagen Peptides] Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study — Nutrients 2018. PMID 29337906
- [Collagen Peptides] Improvement of activity-related knee joint discomfort following supplementation of specific collagen peptides — Appl Physiol Nutr Metab 2017. PMID 28177710
- [Matrixyl] Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin — Int J Cosmet Sci 2005. PMID 18492182
- [Matrixyl] Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS) — Biomol Ther (Seoul) 2014. PMID 25143811
- [Matrixyl] Effect of Palmitoyl-Pentapeptide (Pal-KTTKS) on Wound Contractile Process in Relation with Connective Tissue Growth Factor and α-Smooth Muscle Actin Expression — Tissue Eng Regen Med 2017. PMID 30603464
FREQUENTLY ASKED
What is the difference between Collagen Peptides and Matrixyl?
Collagen peptides are taken orally and studied for skin elasticity and hydration in randomised trials; Matrixyl is applied topically as a short signal peptide.
What is the regulatory status of Collagen Peptides and Matrixyl?
Collagen Peptides: Food supplement with multiple small randomised trials in skin ageing, activity-related knee pain and postmenopausal bone density. Matrixyl: Cosmetic ingredient with small clinical studies and in-vitro work; delivery systems remain an active topic.
What safety signals have been reported?
Collagen Peptides: Trials report it as well tolerated. Matrixyl: Topical studies report good tolerability.
Which studies is this comparison based on?
For Collagen Peptides: “Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis” (PMID 24401291); “Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study” (PMID 29337906); “Improvement of activity-related knee joint discomfort following supplementation of specific collagen peptides” (PMID 28177710). For Matrixyl: “Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin” (PMID 18492182); “Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS)” (PMID 25143811); “Effect of Palmitoyl-Pentapeptide (Pal-KTTKS) on Wound Contractile Process in Relation with Connective Tissue Growth Factor and α-Smooth Muscle Actin Expression” (PMID 30603464).
MORE COMPARISONS
All products supplied for research purposes only. Not for human consumption.
In stock · ships from South Africa
Shop this comparison
Supplied for laboratory research only · not for human use






